cthomas

Posts by cthomas
Guidance on the Health Institution Exemption Under Article 5(5) of EU MDR and EU IVDR
doctor using tablet in medical room
EU

Guidance on the Health Institution Exemption Under Article 5(5) of EU MDR and EU IVDR

February 2, 2023 3 min read
Understanding FDA’s Draft Guidance Document on Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers
voluntary malfunction summary report word cloud

Understanding FDA’s Draft Guidance Document on Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers

January 13, 2023 4 min read
European Union Clinical Trials Regulation: Mandatory Deadline Approaching
deadline ahead with an alarm clock

European Union Clinical Trials Regulation: Mandatory Deadline Approaching

December 20, 2022 3 min read
Part 3 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December
part 3 aligning FDA regulations with the common rule

Part 3 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December

December 12, 2022 4 min read
Part 2 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA regulations with the Common Rule – Comment Period Extended until December
metal blocks saying part 2

Part 2 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA regulations with the Common Rule – Comment Period Extended until December

December 5, 2022 4 min read
Part 1 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December
part 1 aligning fda regulations with the common rule

Part 1 of 3 — Making Amends in Clinical Investigation Requirements: Aligning FDA Regulations with the Common Rule – Comment Period Extended until December

November 29, 2022 2 min read
‘Scorecard’ By Notified Body BSI Affixes Mediocre ‘Yellow’ Designation To Second Half Of E.U.’s 19-Point MDR/IVDR Compliance Plan (2 Of 2)
frowning yellow face on a light blue background

‘Scorecard’ By Notified Body BSI Affixes Mediocre ‘Yellow’ Designation To Second Half Of E.U.’s 19-Point MDR/IVDR Compliance Plan (2 Of 2)

November 8, 2022 9 min read
International Group ICH Offers Detailed Protocol Template For Clinical Trials
protocol tab on computer interface with cursor hovering over it

International Group ICH Offers Detailed Protocol Template For Clinical Trials

November 7, 2022 2 min read
New FDA ‘TAP’ Pilot Wants To Help Companies Traverse ‘Valley Of Death’ By Streamlining The Product Clearance Process. First Up: Cardiovascular Devices
business man looking down long road

New FDA ‘TAP’ Pilot Wants To Help Companies Traverse ‘Valley Of Death’ By Streamlining The Product Clearance Process. First Up: Cardiovascular Devices

October 13, 2022 3 min read

Patients Are Waiting.

Every submission, study, inspection, and commercialization decision moves a patient closer to the technology they're waiting for. Partner with Medicept to navigate every milestone with clarity, continuity, and confidence.